Jouko I T Isojarvi
Overview
Explore the profile of Jouko I T Isojarvi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mikkonen K, Tapanainen P, Pakarinen A, Paivansalo M, Isojarvi J, Vainionpaa L
Epilepsia
. 2004 Jul;
45(7):769-76.
PMID: 15230700
Purpose: To evaluate reproductive endocrine function in boys and young men with epilepsy taking an antiepileptic drug in a population-based, controlled study. Methods: Seventy patients and 70 controls matched for...
12.
Vainionpaa L, Mikkonen K, Rattya J, Knip M, Pakarinen A, Myllyla V, et al.
Epilepsia
. 2004 Mar;
45(3):197-203.
PMID: 15009219
Purpose: Antiepileptic drugs may affect the serum thyroid hormone concentrations. The aim of this study was to evaluate thyroid function in 78 girls taking carbamazepine (CBZ), oxcarbazepine (OXC), or valproate...
13.
Roste L, Tauboll E, Isojarvi J, Berner A, Berg K, Pakarinen A, et al.
Seizure
. 2003 Nov;
12(8):621-7.
PMID: 14630507
Drug-induced disturbances in reproductive hormones and gonadal morphology have been observed both in patients with epilepsy and in non-epileptic animals. Less is known about the influence of newer antiepileptic drugs...
14.
Isojarvi J
Neurology
. 2003 Sep;
61(6 Suppl 2):S27-34.
PMID: 14504307
Reproductive endocrine disorders, such as polycystic ovary syndrome (PCOS), hypothalamic amenorrhea, premature menopause, and hyperprolactinemia, are reported to be more common in women with epilepsy than in the general female...
15.
Roste L, Tauboll E, Isojarvi J, Pakarinen A, Huhtaniemi I, Knip M, et al.
Reprod Toxicol
. 2002 Oct;
16(6):767-73.
PMID: 12401504
Valproate (VPA) has been claimed to induce endocrine disorders in both sexes in humans. There is sparse information regarding the mechanisms behind these disturbances. By using an animal model, we...
16.
Pylvanen V, Knip M, Pakarinen A, Kotila M, Turkka J, Isojarvi J
Epilepsia
. 2002 May;
43(5):514-7.
PMID: 12027912
Purpose: Weight gain is an important adverse effect of valproate (VPA) therapy, and it is associated with hyperinsulinemia and hyperandrogenism in women with epilepsy. Leptin is considered a signaling factor...